- CDC recommended resuming administration of Johnson & Johnson’s covid-19 vaccine
- It had been suspended since on April 13, the Government recommended pausing use of the vaccine after the detection of six cases of cerebral thrombosis in women
- They added that the vaccine should come with a warning about potential health risks.
CDC resumes Johnson & Johnson vaccine. This Friday an advisory committee of the Centers for Disease Control and Prevention (CDC) recommended to resume the administration of the Johnson & Johnson vaccine against coronavirus, this after it was suspended due to several cases of thrombosis, according to Efe.
This vaccine, which was being applied previously, has been practically suspended since the Government of the United States paused its use on April 13 after the detection of six cases of cerebral thrombosis in women, this recommendation will serve as a guide to health authorities on what to do from now on with the application of the dose. However, this Friday the US health authorities lifted the restriction against the vaccine, reports AP.
CDC recommended resuming administration of Johnson & Johnson vaccine
Previously, the fifteen experts of the Advisory Committee on Immunization Practices (ACIP) of the CDC voted mostly in favor of the recommendation on resuming applications, in total there were 10 experts who liked the idea, while 4 opposed and one abstention, but they said the vaccine should be accompanied by a warning about potential health risks.
During the debate, the scientists had evaluated four options when updating the recommendation on the vaccine, which until this Friday has caused fifteen cases of clots, most of them brain thromboses, in women of different ages, of which three have died.
Women developed post-dose thrombosis
Some of the alternatives ranged from advising against its use to recommending it for all ages and genders, but displaying a caveat. The other two options were to warn women under 50 years of possible risks of cerebral thrombosis or to suggest its administration only to adults of both sexes older than that age.
Most of the patients who presented symptoms after being vaccinated are in their 30s, although there have been cases in women between 18 and 59 years old. All but two of those affected were under 50 years of age. During the meeting, one of the experts mentioned that there may be potential cases in vaccinated men.
It must be signed by the director of the CDC
The ACIP recommendation must now be signed by CDC Director Rochelle Walensky before the Food and Drug Administration (FDA) undertakes any changes to the J&J vaccine labeling.
The committee meeting was attended by representatives of J&J, who before the vote stated that they had agreed with the FDA to add to the labeling a notice that there may be a risk of blood clots So that people who decide to apply the dose are aware of possible symptoms. Filed Under: CDC Resume Johnson & Johnson Vaccine.
15 confirmed cases of clots
The United States has detected at least 15 confirmed cases of clots, including brain thrombosis, in women who have received the covid-19 vaccine from Janssen, the Belgian subsidiary of Johnson & Johnson (J&J).
This was announced at a meeting of the Advisory Committee on Immunization Practices (ACIP), a body made up of 15 independent scientists that is evaluating the data on this serum before issuing a recommendation that will guide US authorities on what to do. with that vaccine from now on. Filed Under: CDC Resume Johnson & Johnson Vaccine.
J&J vaccine suspension
The United States country advised on April 13 to suspend the administration of the J&J vaccine after six cases of cerebral thrombosis were initially detected in women under 48 years of age, of which one died. Being one of the causes of suspension.
During the ACIP session, Dr. Tom Shimabukuro, head of vaccine safety at the Centers for Disease Control and Prevention (CDC), updated that data, noting that there are three deaths so far, and seven are still hospitalized, of which four are in intensive care units. Filed Under: CDC Resume Johnson & Johnson Vaccine.
CDC Resume Vaccine: Clot Symptoms
Of the 15 patients, 13 are between 18 and 49 years old, and 12 of them developed cerebral thrombosis, although many had clots in other parts of the body. For this reason they decided to suspend the application of the vaccine in people, but apparently they will apply it again, according to Agencia Efe.
The initial symptom was headache, which usually began six days after being vaccinated, although, as time passed, the patients developed nausea, vomiting, abdominal pain, weakness on one side of the body, difficulties speaking, loss of consciousness and spasms, detailed the doctor. Filed Under: CDC Resume Johnson & Johnson Vaccine.
CDC Resume Vaccine: Possible Risks
The doctor Shimabukuro highlighted that seven of the women were obese, two had hypothyroidism, two had high blood pressure and two others were taking contraceptives. These people were the ones who presented the symptoms of thrombosis, after applying the Johnson & Johnson vaccine.
It is not clear at this time if any of these factors could contribute to increasing the risk of developing thrombi.
For now, 8 million doses of J&J have been injected in the US, whose administration has practically been paused in the country after the recommendation of last day 13. Filed under: CDC to resume Johnson & Johnson vaccine.
CDC Resume Vaccine: Possible Risk Labels
Shimabukuro said there could be potential cases in men and they are currently being studied. Specifically, the scientist mentioned a 25-year-old patient who developed a clot when he participated in clinical trials of the aforementioned vaccine, which has generated controversy.
Representatives of J&J participate in today’s meeting, who assured that these cases are being taken “very seriously.” The company supports putting a label on the vaccine warning of potential risks. Filed Under: CDC Resume Johnson & Johnson Vaccine.
CDC Vaccine Resume: Review Vaccine Data
ACIP is comprised of 15 independent experts and plans to review vaccine data until 5:00 p.m. EDT this Friday. At the end of the session it is expected that a recommendation will be voted on what to do from now on with the J&J serum.
If ACIP advises any changes to the vaccine’s label, such as a warning about potential risks or a recommendation that it be administered only to certain population groups, CDC Director Rochelle Walensky should sign it later, before the FDA will be in charge of making any changes to the labeling. Filed Under: CDC Resume Johnson & Johnson Vaccine.
The US finds problems in a plant that manufactured J&J vaccine
The Baltimore plant contracted to make Johnson & Johnson’s COVID-19 vaccine was dirty, did not follow production protocols, and its staff were not trained, resulting in contamination of injection material, they revealed Wednesday. US regulators, according to AP.
The Food and Drug Administration (FDA) issued a report on its recent inspection of the Emergent Biosciences factory, whose production was halted. Inspectors said a batch of the substance used for J & J’s vaccine, which requires a single injection, was contaminated with material used for COVID-19 vaccines from another company customer, AstraZeneca. Filed Under: CDC Resume Johnson & Johnson Vaccine.
The post After a hiatus, CDC recommends resuming Johnson & Johnson vaccine administration appeared first on Hispanic World.